The Global Mucopolysaccharidosis (MPS) Treatment Market is estimated to be valued at US$ 1,566.5 million in 2020 and is expected to exhibit a CAGR of 9% over the forecast period 2022-2028. Mucopolysaccharides are a group of genetic disorders in which the body cannot properly break down mucopolysaccharides, the long-chain sugar molecules found in the body. As a result, these sugars can build up in […]
